<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>LegalNewsWatch &#187; Rezulin</title>
	<atom:link href="http://www.legalnewswatch.com/tags/rezulin/feed" rel="self" type="application/rss+xml" />
	<link>http://www.legalnewswatch.com</link>
	<description>Stories That Impact Your Rights</description>
	<lastBuildDate>Thu, 16 Jul 2009 02:38:59 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pfizer Agrees to Pay $60M to Settle Rezulin Class-Action Lawsuit</title>
		<link>http://www.legalnewswatch.com/386/pfizer-agrees-to-pay-60m-to-settle-rezulin-class-action-lawsuit</link>
		<comments>http://www.legalnewswatch.com/386/pfizer-agrees-to-pay-60m-to-settle-rezulin-class-action-lawsuit#comments</comments>
		<pubDate>Thu, 08 Jul 2004 19:43:05 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Rezulin]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=386</guid>
		<description><![CDATA[Drug giant Pfizer Inc. has agreed to pay $60 million to settle a class-action lawsuit that accused the company of falsely marketing its diabetes drug Rezulin.
The lawsuit was brought on behalf of purchasers of Rezulin who live in Illinois. It sought a refund for all Rezulin tablets they had purchased. 
Pfizer admitted to no wrong [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/386/pfizer-agrees-to-pay-60m-to-settle-rezulin-class-action-lawsuit/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Court Certifies Rezulin Class-Action Lawsuit</title>
		<link>http://www.legalnewswatch.com/238/court-certifies-rezulin-class-action-lawsuit</link>
		<comments>http://www.legalnewswatch.com/238/court-certifies-rezulin-class-action-lawsuit#comments</comments>
		<pubDate>Wed, 23 Jul 2003 18:41:57 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Rezulin]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=238</guid>
		<description><![CDATA[The West Virginia Supreme Court of Appeals approved certification of a Rezulin class-action lawsuit against Pfizer, reversing a lower court&#8217;s November 2001 decision. The ruling also orders the lawsuit returned to trial court for further proceedings as a class action.
The Rezulin class-action lawsuit was brought on behalf of 5,000 West Virginians who seek to recover [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/238/court-certifies-rezulin-class-action-lawsuit/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Jury Orders Pfizer to Pay Damages for Rezulin</title>
		<link>http://www.legalnewswatch.com/179/jury-orders-pfizer-to-pay-damages-for-rezulin</link>
		<comments>http://www.legalnewswatch.com/179/jury-orders-pfizer-to-pay-damages-for-rezulin#comments</comments>
		<pubDate>Fri, 04 Apr 2003 19:07:51 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Rezulin]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=179</guid>
		<description><![CDATA[Pfizer was ordered to pay $2 million in compensatory damages to Concepcion Morgado who was injured after taking the recalled diabetes drug Rezulin. Pfizer faces thousands of lawsuits alleging that Warner-Lambert, which it acquired in June 2000, failed to inform the public of Rezulin&#8217;s dangerous side effects. Rezulin was supplied by Warner-Lambert.
Morgado&#8217;s attorney said in [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/179/jury-orders-pfizer-to-pay-damages-for-rezulin/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
